ALNA Insider Trading Activity and SEC Form 4 Filings
ALNA insider trading summary
No open-market insider purchases or sales of Allena Pharmaceuticals, Inc. (ALNA) have been reported on SEC Form 4 in the past 12 months.
Latest ALNA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 15, 2021 | Louis Md Brenner | President and CEO | Sell | $33K (40,328 @ $0.81) |
| May 10, 2021 | Louis Md Brenner | President and COO | Sell | $28K (25,215 @ $1.11) |
| Dec 17, 2020 | Edward Wholihan | Chief Financial Officer | Sell | $93K (68,550 @ $1.36) |
| Dec 17, 2020 | Louis Md Brenner | President and CEO | Sell | $140K (103,116 @ $1.36) |
| Nov 6, 2017 | Robert I Tepper | Director | Buy | $3.0M (215,000 @ $14.00) |
| Nov 6, 2017 | Third Rock Ventures GP II, L.P. | 10% Owner | Buy | $3.0M (215,000 @ $14.00) |
| Nov 6, 2017 | Kevin P Starr | 10% Owner | Buy | $3.0M (215,000 @ $14.00) |
| Nov 6, 2017 | Mark J Levin | 10% Owner | Buy | $3.0M (215,000 @ $14.00) |
| Nov 6, 2017 | Trv Gp II, LLC | 10% Owner | Buy | $3.0M (215,000 @ $14.00) |
| Nov 6, 2017 | Third Rock Ventures II, L.P. | 10% Owner | Buy | $3.0M (215,000 @ $14.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.